2026-05-06 12:50:06
Generation H 3.0: Serhiy Tokarev discusses the launch of the HealthTech accelerator
La maggior parte ha letto le notizie
Investor and IT entrepreneur Serhiy Tokarev has announced the launch of the Generation H 3.0 programme, which is now open to teams from abroad A new round of applications for Generation H, a MedTech startup programme, has begun in Ukraine. One of the key updates is that teams from abroad can now apply. The grand prize is UAH 650,000 in investment. This was announced by Serhiy Tokarev , an impact-investor, IT entrepreneur, and founder of the Tokarev Foundation. The decision to scale up Generation H is directly linked to the growth of the HealthTech market, which has already surpassed $300 billion, while AI technologies in medicine are growing by 35–40% annually. What we know about the accelerator The programme is open to start-ups with a ready MVP or a product that has already generated initial sales and is ready to scale within a short timeframe. Participants will gain access to workshops on entering international markets, one-to-one matchmaking with investors, personalised mentoring, business model validation, product crash tests, and support on regulatory issues. The programme’s third season will be delivered in a hybrid format. International participants will be able to take part online without having to travel. Applications must be submitted by 24 May via the SET University website. The mentors include professionals with real-world experience, such as: Eric Henry — Senior Advisor on FDA Compliance at King & Spalding Fergus O’Dea — Vice President of Commercial Operations at FIRE1 Vladimir Nerubenko — co-founder of the Liki24 Foundation and TerraLab Alexa Sinyacheva — co-founder of Moeco and Techstars mentor What has been achieved in previous seasons Over the past two years, 30 projects have gone through Generation H. In total, the graduates have secured over UAH 11 million in investment, won competitions such as IT Arena, EIT Jumpstarter, and Google for Startups, and entered the US and European markets. Among the most notable start-ups are: M Shield — a drug being developed to prevent the spread of metastases Ovul — an AI device for tracking fertility through saliva analysis TAYRA.AI — an AI medical assistant that automatically structures doctors’ consultations “I invest in HealthTech because this sector offers the shortest route from technology to tangible improvements in quality of life. However, in addition to a strong product, it is also essential to understand medical logic, regulatory frameworks, and decision-making processes. That is why acceleration programmes and mentoring are essential here,” says Serhiy Tokarev. Disclaimer : This content is meant to inform and should not be considered financial advice. The views expressed in this article may include the author’s personal opinions and do not represent Times Tabloid’s opinion. Readers are advised to conduct thorough research before making any investment decisions. Any action taken by the reader is strictly at their own risk. Times Tabloid is not responsible for any financial losses. The post Generation H 3.0: Serhiy Tokarev discusses the launch of the HealthTech accelerator appeared first on Times Tabloid .